Envestnet Asset Management
ARCT icon

Envestnet Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Envestnet Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,768
Closed -$403K – 3635
2021
Q1 		$403K Buy
+9,768
New +$582K ﹤0.01% 2970

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return

Envestnet Asset Management's ARCT Position: Q2 2021 in Review

Envestnet Asset Management sold out of Arcturus Therapeutics (ARCT) in Q2 2021, closing a stake of 9,768 shares — an estimated $403K sold.

Envestnet Asset Management first reported a position in ARCT in Q1 2021 and held it in 1 quarter. The position peaked at $403K in Q1 2021. 139 funds tracked by Wall St. Rank hold ARCT as of Q2 2021.

  • Envestnet Asset Management reported no remaining Arcturus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 9,768 Arcturus Therapeutics shares in Q2 2021, an estimated $403K.
  • Envestnet Asset Management first reported a position in Arcturus Therapeutics in Q1 2021 and held it in 1 quarter.
  • Envestnet Asset Management's Arcturus Therapeutics position peaked at $403K in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2021.

Based on Envestnet Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.